2013
DOI: 10.1039/c3md00061c
|View full text |Cite
|
Sign up to set email alerts
|

Bridged tetrahydroisoquinolines as selective NADPH oxidase 2 (Nox2) inhibitors

Abstract: (1SR,4RS)-3,3-Dimethyl-1,2,3,4-tetrahydro-1,4-(epiminomethano)naphthalenes were synthesized in 2-3 steps from commercially available materials and assessed for specificity and effectiveness across a range of Nox isoforms. The N-pentyl and N-methylenethiophene substituted analogs 11g and 11h emerged as selective Nox2 inhibitors with cellular IC50 values of 20 and 32 μM, respectively.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
29
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
7
1
1

Relationship

2
7

Authors

Journals

citations
Cited by 31 publications
(29 citation statements)
references
References 59 publications
0
29
0
Order By: Relevance
“…The authors further noted that the anti-ROS therapy decreased cerebral amyloid angiopathy and micro-hemorrhage that commonly occur in Alzheimer’s Disease [188]. As all these studies point to the key contribution of the Nox, particularly Nox2, to aging-elicited cerebrovascular dysfunction, Nox2 inhibition holds great promise as a therapeutic strategy [52,189191] for restoring vascular health in cerebral microcirculation, and hopefully delaying the onset of cognitive impairment.…”
Section: Cerebral Microcirculationmentioning
confidence: 99%
See 1 more Smart Citation
“…The authors further noted that the anti-ROS therapy decreased cerebral amyloid angiopathy and micro-hemorrhage that commonly occur in Alzheimer’s Disease [188]. As all these studies point to the key contribution of the Nox, particularly Nox2, to aging-elicited cerebrovascular dysfunction, Nox2 inhibition holds great promise as a therapeutic strategy [52,189191] for restoring vascular health in cerebral microcirculation, and hopefully delaying the onset of cognitive impairment.…”
Section: Cerebral Microcirculationmentioning
confidence: 99%
“…Using high throughput screening and rational design, our laboratory identified bridged tetrahydroquinolines as specific Nox2 inhibitors [191]. Among a group of structurally related molecules, compounds 11 g [(±)-(1S,4R,9S)-5-bromo-3,3-dimethyl-9-(2-methylallyl)−10-pentyl-1,2,3,4-tetrahydro-1,3-(epiminomehono) naphthalene] and 11 h [(±)-(1S,4R,9S)-5-bromo-3,3-dimethyl-9-(2-methyallyl)-10-(thiophen-2-ylmethyl)-1,2,3,4-tetrahydro-1,4-(epino-methano)naphthalene] displayed isoform-selective inhibition on Nox2 in intact COS-Nox2 cells with IC 50 of 20 μM and 32 μM, respectively.…”
Section: Nox Inhibitors As Therapeutics For Microvascular Diseasesmentioning
confidence: 99%
“…Like the first-generation GKT inhibitor, issues of Nox specificity are still a concern with regard to untoward and off-target effects of these drugs. Novel approaches and rational drug design strategies have yielded isoform selectivity for Nox2 and been discussed in greater detail [107,108,247,258,266]. Assuredly with these innovative approaches, new isoform-specific Nox therapeutics are expected to gain greater traction.…”
Section: Nox In Age-associated Cvdmentioning
confidence: 99%
“…Despite decades of research, only a limited number of Nox inhibitors are currently available, few if any of which are isoform-specific; researchers are therefore actively seeking new small molecules as isoform-selective Nox inhibitors (17)(18)(19)(20). The limited progress thus far is due in part to limitations of the assays that are currently in use for detection and quantitation of ROS (21).…”
mentioning
confidence: 99%